For its key role as sensor of DNA damage, p53 undergoes inactivation, both at genetic and/or protein level, in almost all tumors [13], and its inactivation predisposes to cancer onset progression and resistance to therapies [14,15]. This evidence concerns the gene TP53 and cancer.